Equities

Krsnaa Diagnostics Ltd

KRSNAA:NSI

Krsnaa Diagnostics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)911.55
  • Today's Change11.55 / 1.28%
  • Shares traded69.40k
  • 1 Year change+43.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Krsnaa Diagnostics Ltd had net income fall -8.49% from 621.11m to 568.37m despite a 27.20% increase in revenues from 4.87bn to 6.20bn. An increase in the cost of goods sold as a percentage of sales from 15.23% to 24.73% was a component in the falling net income despite rising revenues.
Gross margin75.75%
Net profit margin10.16%
Operating margin13.23%
Return on assets5.84%
Return on equity8.67%
Return on investment7.91%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Krsnaa Diagnostics Ltd fell by 203.45m. Cash Flow from Financing totalled 841.87m or 13.59% of revenues. In addition the company generated 243.45m in cash from operations while cash used for investing totalled 1.29bn.
Cash flow per share46.02
Price/Cash flow per share19.08
Book value per share260.38
Tangible book value per share259.66
More ▼

Balance sheet in INRView more

Krsnaa Diagnostics Ltd has a Debt to Total Capital ratio of 20.45%, a higher figure than the previous year's 5.03%.
Current ratio1.09
Quick ratio1.01
Total debt/total equity0.257
Total debt/total capital0.2045
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.